Skip to main content
Premium Trial:

Request an Annual Quote

ChemoCentryx Awarded US Patent

Premium
ChemoCentryx has been awarded US Patent 7,396,653, “Cell migration assay.”
 
The inventors listed on the patent are Zheng Wei and Zhenhua Miao.
 
As stated in its abstract, the patent describes a modified cell migration assay allowing for the improved identification and discrimination of chemokine receptor antagonists from non-specific receptor blockers.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more